ID   CSML-100
AC   CVCL_0226
SY   CSML100
DR   MCCL; MCC:0000114
DR   Wikidata; Q54814669
RX   CelloPub=CLPUB00133;
RX   PubMed=2550322;
RX   PubMed=11329088;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: A/Sn.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E114 ! CSML-0
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
RX   CelloPub=CLPUB00133;
RA   Georgiev G.P., Kiselev S.L., Lukanidin E.M.;
RT   "Genes involved in the control of tumor progression and their possible
RT   use for gene therapy.";
RL   Gene Ther. Mol. Biol. 1:381-398(1998).
//
RX   PubMed=2550322; DOI=10.1101/gad.3.7.1086;
RA   Ebralidze A., Tulchinsky E.M., Grigorian M., Afanasyeva A.V.,
RA   Senin V.M., Revazova E., Lukanidin E.M.;
RT   "Isolation and characterization of a gene specifically expressed in
RT   different metastatic cells and whose deduced gene product has a high
RT   degree of homology to a Ca2+-binding protein family.";
RL   Genes Dev. 3:1086-1093(1989).
//
RX   PubMed=11329088; DOI=10.1023/A:1017594932500;
RA   Dukhanin A.S., Romanova E.A., Dukhanina E.A.;
RT   "Molecular mechanisms of different sensitivity of tumor cells to
RT   dexamethasone.";
RL   Bull. Exp. Biol. Med. 131:73-76(2001).
//